These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12140772)

  • 1. Nicotinic acetylcholine receptors as targets for antidepressants.
    Shytle RD; Silver AA; Lukas RJ; Newman MB; Sheehan DV; Sanberg PR
    Mol Psychiatry; 2002; 7(6):525-35. PubMed ID: 12140772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.
    Shytle RD; Silver AA; Sheehan KH; Sheehan DV; Sanberg PR
    Depress Anxiety; 2002; 16(3):89-92. PubMed ID: 12415531
    [No Abstract]   [Full Text] [Related]  

  • 5. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic cholinergic antagonists: a novel approach for the treatment of autism.
    Lippiello PM
    Med Hypotheses; 2006; 66(5):985-90. PubMed ID: 16406687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex.
    Andreasen JT; Redrobe JP
    Behav Pharmacol; 2009 May; 20(3):286-95. PubMed ID: 19404193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.
    Popik P; Kozela E; Krawczyk M
    Br J Pharmacol; 2003 Jul; 139(6):1196-202. PubMed ID: 12871839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice.
    Roni MA; Rahman S
    Neurosci Lett; 2011 Oct; 504(3):237-41. PubMed ID: 21964392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.
    Mineur YS; Picciotto MR
    Trends Pharmacol Sci; 2010 Dec; 31(12):580-6. PubMed ID: 20965579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of subunit composition on the inhibition of nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoate.
    Papke RL; Buhr JD; Francis MM; Choi KI; Thinschmidt JS; Horenstein NA
    Mol Pharmacol; 2005 Jun; 67(6):1977-90. PubMed ID: 15761116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of A-85380 in an animal model of depression.
    Buckley MJ; Surowy C; Meyer M; Curzon P
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):723-30. PubMed ID: 15276699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of peripheral and central nicotinic receptors in the micturition reflex in rats.
    Masuda H; Hayashi Y; Chancellor MB; Kihara K; de Groat WC; de Miguel F; Yoshimura N
    J Urol; 2006 Jul; 176(1):374-9. PubMed ID: 16753446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
    Freir DB; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):2917-22. PubMed ID: 12611941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD).
    Lindsley CW
    ACS Chem Neurosci; 2010 Aug; 1(8):530-1. PubMed ID: 22778844
    [No Abstract]   [Full Text] [Related]  

  • 18. GABAergic systems modulate nicotinic receptor-mediated seizures in mice.
    Dobelis P; Hutton S; Lu Y; Collins AC
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1159-66. PubMed ID: 12829730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Painful physical symptoms in depression: a clinical challenge.
    Wise TN; Fishbain DA; Holder-Perkins V
    Pain Med; 2007 Sep; 8 Suppl 2():S75-82. PubMed ID: 17714118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
    Nemeroff CB
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-6. PubMed ID: 12404664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.